GENENTECH  - NSCLC (ATLAS)
1ST LINE Stage IIIB WITH MALIGNANT PLEURAL EFFUSION & STAGE IV NSCLC STUDY of 4 CYCLES Chemotherapy & Bevacizumab FOLLOWED BY AVASTIN PLUS/MINUS Erlotinib 
**NON-SQUAMOUS CELL CA.
AVASTIN & TARCEVA PROVIDED

GENETECH – NSCLC (BRIDGE)
A Pilot Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects with Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer
AVASTIN PROVIDED

MERCK
“Randomized, double blind placebo-controlled study of the cancer vaccine Stimuvax (L-BLP25 or BLP25 liposome vaccine) in non-small cell lung cancer (NSCLC) subjects with unresectable
stage III disease”

CHROMO THERAPEUTICS
A Phase I-II, Multicenter, Open-label Trial of Co-administered CHR 2797 and Erlotinib in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer

IMCLONE/BMS
A Phase II Randomized, Open-Label Study of Cetuximab and Bevacizumab in Combination with Paclitaxel and Carboplatin in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

GENZYME
PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUSLY ADMINISTERED CAMPATH® IN PATIENTS WITH PREVIOUSLY TREATED B CELL CHRONIC LYMPHOCYTIC LEUKEMIA. – CAMPATH PROVIDED

MISCELLANEOUS

ENDO
Open-Label, ONE YEAR STUDY OF SUB-LINGUEL FENTANYL FOR Breakthrough Pain in Cancer Patients
DRUG PROVIDED

A P PHARMA
A Observer-Blind, Randomized Trial of SQ POLERMERIZED KYTRIL Compared to Aloxi™ for CINV  WITH Moderately or Highly Emetogenic Chemotherapy Regimens. ***CAN BE ENROLLED AT ANY CYCLE
DRUGS PROVIDED

ALEXION PHARMACEUTICALS
EXAMINATION OF PNH, BY LEVEL OF CD59 ON RED AND WHITE CELLS, IN BONE MARROW FAILURE SYNDROMES

GENENTECH
A Randomized, Blinded, Placebo-Controlled, Study of Bevacizumab VS PLACEBO in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma.
AVASTIN/ PLACEBO PROVIDED FOR 8 CYCLES, THEN OPEN LABEL THEREAFTER.

MILLENNIUM
OPEN-LABEL, RANDOMIZED 3-ARM COMPARATIVE STUDY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA NOT ELIGIBLE FOR HIGH DOSE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION.
VELCADE AND THALIDOMIDE PROVIDED.